Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003766998 | SCV000638211 | likely benign | Cutis laxa, autosomal dominant 3; Autosomal dominant spastic paraplegia type 9; de Barsy syndrome | 2023-09-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848936 | SCV002104506 | uncertain significance | Hereditary spastic paraplegia | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002526112 | SCV003596560 | uncertain significance | Inborn genetic diseases | 2022-02-25 | criteria provided, single submitter | clinical testing | Unlikely to be causative of P5CS deficiency (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003424107 | SCV004127147 | uncertain significance | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003424107 | SCV005190948 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV003424107 | SCV005412184 | uncertain significance | not provided | 2023-07-26 | criteria provided, single submitter | clinical testing | BP4 |